1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
180
Biomédica 2018;38:180-8
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
National Tuberclosis and
Leprosy Programme (NTLP)
Revised National Tuberculosis Control Programme
Towards Universal Access to Prevention, Diagnosis and Treatment